Sector Gamma As Ionis Pharmaceuticals Inc Transaction History

Sector Gamma As

$276 Million
Q4 2024

A detailed history of Sector Gamma As transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Sector Gamma As holds 235,842 shares of IONS stock, worth $7.52 Million. This represents 2.99% of its overall portfolio holdings.

Number of Shares

235,842

Previous 210,842 11.86%

Holding current value

$7.52 Million

Previous $8.45 Million 2.38%

% of portfolio

2.99%

Previous 2.73%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$33.73 - $40.36 $843,249 - $1.01 Million	25,000 Added 11.86%	235,842 $8.25 Million
Q3 2024 Nov 13, 2024	BUY	$40.06 - $51.86 $1.64 Million - $2.12 Million	40,842 Added 24.02%	210,842 $8.45 Million
Q2 2024 Aug 09, 2024	SELL	$36.45 - $47.7 $200,730 - $262,683	-5,507 Reduced 3.14%	170,000 $8.1 Million
Q1 2024 May 08, 2024	BUY	$42.03 - $53.55 $1.28 Million - $1.63 Million	30,495 Added 21.03%	175,507 $7.61 Million
Q4 2023 Feb 05, 2024	SELL	$43.39 - $51.63 $894,007 - $1.06 Million	-20,604 Reduced 12.44%	145,012 $7.34 Million
Q3 2023 Nov 06, 2023	BUY	$38.5 - $47.13 $200,777 - $245,782	5,215 Added 3.25%	165,616 $7.51 Million
Q2 2023 Aug 09, 2023	BUY	$34.73 - $43.33 $484,830 - $604,886	13,960 Added 9.53%	160,401 $6.58 Million
Q1 2023 May 12, 2023	BUY	$33.58 - $41.2 $170,183 - $208,801	5,068 Added 3.58%	146,441 $5.23 Million
Q4 2022 Feb 07, 2023	SELL	$37.12 - $46.52 $848,191 - $1.06 Million	-22,850 Reduced 13.91%	141,373 $5.34 Million
Q3 2022 Nov 09, 2022	SELL	$36.54 - $48.66 $44,432 - $59,170	-1,216 Reduced 0.74%	164,223 $7.26 Million
Q2 2022 Aug 05, 2022	SELL	$31.71 - $43.0 $729,330 - $989,000	-23,000 Reduced 12.21%	165,439 $6.13 Million
Q1 2022 May 06, 2022	SELL	$29.88 - $37.04 $630,408 - $781,469	-21,098 Reduced 10.07%	188,439 $6.98 Million
Q4 2021 Feb 08, 2022	SELL	$25.61 - $35.1 $1.39 Million - $1.91 Million	-54,333 Reduced 20.59%	209,537 $6.38 Million
Q3 2021 Oct 29, 2021	BUY	$33.54 - $40.55 $12,812 - $15,490	382 Added 0.14%	263,870 $8.85 Million
Q2 2021 Aug 04, 2021	SELL	$34.54 - $47.25 $6.59 Million - $9.01 Million	-190,662 Reduced 41.98%	263,488 $10.5 Million
Q1 2021 May 10, 2021	BUY	$42.51 - $63.78 $5.66 Million - $8.49 Million	133,158 Added 41.48%	454,150 $20.4 Million
Q4 2020 Feb 10, 2021	BUY	$45.3 - $60.27 $3.83 Million - $5.1 Million	84,650 Added 35.82%	320,992 $18.1 Million
Q3 2020 Nov 09, 2020	BUY	$47.45 - $62.95 $2.2 Million - $2.92 Million	46,361 Added 24.4%	236,342 $11.2 Million
Q2 2020 Aug 07, 2020	SELL	$46.85 - $61.05 $4.01 Million - $5.22 Million	-85,500 Reduced 31.04%	189,981 $11.2 Million
Q1 2020 May 11, 2020	BUY	$41.6 - $63.4 $2.41 Million - $3.67 Million	57,846 Added 26.58%	275,481 $13 Million
Q4 2019 Feb 12, 2020	BUY	$53.85 - $65.27 $4.64 Million - $5.62 Million	86,121 Added 65.48%	217,635 $13.1 Million
Q2 2019 Jul 31, 2019	SELL	$62.09 - $86.14 $6.35 Million - $8.8 Million	-102,200 Reduced 43.73%	131,514 $8.45 Million
Q1 2019 May 13, 2019	SELL	$52.92 - $81.17 $7.71 Million - $11.8 Million	-145,707 Reduced 38.4%	233,714 $19 Million
Q4 2018 Feb 12, 2019	BUY	$43.37 - $59.54 $7.68 Million - $10.5 Million	176,987 Added 87.43%	379,421 $20.5 Million
Q3 2018 Nov 15, 2018	BUY	$42.88 - $53.7 $3.8 Million - $4.75 Million	88,524 Added 77.71%	202,434 $10.4 Million
Q3 2018 Nov 08, 2018	SELL	$42.88 - $53.7 $8.12 Million - $10.2 Million	-189,330 Reduced 62.44%	113,910 $5.88 Million
Q2 2018 Aug 02, 2018	BUY	$40.53 - $50.7 $1.21 Million - $1.51 Million	29,740 Added 10.87%	303,240 $12.6 Million
Q1 2018 May 09, 2018	BUY	$44.08 - $55.05 $9.32 Million - $11.6 Million	211,400 Added 340.42%	273,500 $12.1 Million
Q4 2017 Feb 12, 2018	BUY	$50.3 - $64.39 $3.12 Million - $4 Million	62,100	62,100 $3.12 Million

Others Institutions Holding IONS

# of Institutions

412

Shares Held

140M

Call Options Held

829K

Put Options Held

789K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.53B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sector Gamma As, based on Form 13F filings with the SEC.

News

Stay updated on Sector Gamma As with notifications on news.

Account